Inhibikase Therapeutics(IKT) - 2023 Q3 - Earnings Call Transcript

3Inhibikase Therapeutics, Inc. (NASDAQ:IKT) Q3 2023 Earnings Conference Call November 15, 2023 8:00 AM ET Company Participants Alex Lobo - IR Milton Werner - CEO Joseph Frattaroli - CFO Conference Call Participants Edward White - H.C. Wainwright Operator Hello, and welcome to the Inhibikase Therapeutics Third Quarter 2023 Financial Results. All participants will be in listen-only mode. [Operator Instructions] After the today’s presentation, there will be an opportunity to ask questions. [Operator Instructio ...